Pfam Domains GO Terms
| PH |
| Dynamin N |
| Dynamin M |
| GED |
| positive regulation of sodium:potassium-exchanging ATPase activity |
| cellular response to carbon monoxide |
| regulation of sodium:potassium-exchanging ATPase activity |
| negative regulation of membrane tubulation |
| negative regulation of non-motile cilium assembly |
| postsynaptic endocytic zone membrane |
| positive regulation of clathrin-dependent endocytosis |
| response to carbon monoxide |
| D2 dopamine receptor binding |
| synaptic vesicle budding from presynaptic endocytic zone membrane |
| regulation of membrane tubulation |
| postsynaptic neurotransmitter receptor internalization |
| postsynaptic endocytosis |
| synaptic vesicle budding |
| macropinocytosis |
| dendritic spine head |
| phosphatidylinositol 3-kinase regulatory subunit binding |
| cellular response to X-ray |
| negative regulation of cilium assembly |
| pinocytosis |
| neurotransmitter receptor internalization |
| regulation of non-motile cilium assembly |
| G protein-coupled receptor internalization |
| nitric-oxide synthase binding |
| regulation of Rac protein signal transduction |
| regulation of plasma membrane organization |
| positive regulation of sodium ion transmembrane transporter activity |
| regulation of Golgi organization |
| cellular response to nitric oxide |
| regulation of clathrin-dependent endocytosis |
| postsynaptic density, intracellular component |
| desensitization of G protein-coupled receptor signaling pathway |
| response to nitric oxide |
| cellular response to reactive nitrogen species |
| negative adaptation of signaling pathway |
| positive regulation of lamellipodium assembly |
| adaptation of signaling pathway |
| positive regulation of sodium ion transmembrane transport |
| positive regulation of potassium ion transmembrane transporter activity |
| negative regulation of plasma membrane bounded cell projection assembly |
| clathrin-coated endocytic vesicle |
| phagocytic cup |
| positive regulation of lamellipodium organization |
| response to X-ray |
| regulation of lamellipodium assembly |
| WW domain binding |
| positive regulation of sodium ion transport |
| neurotransmitter receptor transport |
| synaptic vesicle transport |
| transferrin transport |
| positive regulation of substrate adhesion-dependent cell spreading |
| negative regulation of organelle assembly |
| positive regulation of potassium ion transmembrane transport |
| positive regulation of nitric oxide biosynthetic process |
| synaptic vesicle localization |
| positive regulation of nitric oxide metabolic process |
| regulation of lamellipodium organization |
| synaptic vesicle endocytosis |
| regulation of nitric-oxide synthase activity |
| presynaptic endocytosis |
| positive regulation of potassium ion transport |
| coronary vasculature development |
| negative regulation of G protein-coupled receptor signaling pathway |
| regulation of postsynaptic membrane neurotransmitter receptor levels |
| photoreceptor inner segment |
| positive regulation of reactive oxygen species biosynthetic process |
| response to bronchodilator |
| aorta development |
| regulation of substrate adhesion-dependent cell spreading |
| positive regulation of receptor-mediated endocytosis |
| synaptic vesicle recycling |
| regulation of sodium ion transmembrane transporter activity |
| clathrin-coated pit |
| regulation of monooxygenase activity |
| response to cocaine |
| regulation of potassium ion transmembrane transporter activity |
| regulation of nitric oxide biosynthetic process |
| Golgi to plasma membrane transport |
| receptor internalization |
| regulation of sodium ion transmembrane transport |
| positive regulation of phagocytosis |
| endocytic vesicle membrane |
| cellular response to ionizing radiation |
| iron ion transport |
| ventricular septum development |
| negative regulation of transforming growth factor beta receptor signaling pathway |
| phagocytic vesicle membrane |
| negative regulation of cellular response to transforming growth factor beta stimulus |
| response to anesthetic |
| regulation of potassium ion transmembrane transport |
| regulation of cilium assembly |
| regulation of reactive oxygen species biosynthetic process |
| artery development |
| cellular response to dopamine |
| response to dopamine |
| regulation of sodium ion transport |
| vesicle-mediated transport to the plasma membrane |
| presynapse |
| ruffle membrane |
| regulation of potassium ion transport |
| positive regulation of reactive oxygen species metabolic process |
| regulation of oxidoreductase activity |
| regulation of phagocytosis |
| vesicle budding from membrane |
| regulation of axon extension |
| antigen processing and presentation of exogenous peptide antigen via MHC class II |
| antigen processing and presentation of peptide antigen via MHC class II |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| regulation of receptor-mediated endocytosis |
| positive regulation of endocytosis |
| positive regulation of plasma membrane bounded cell projection assembly |
| cellular response to monoamine stimulus |
| cellular response to catecholamine stimulus |
| post-Golgi vesicle-mediated transport |
| positive regulation of ion transmembrane transporter activity |
| receptor metabolic process |
| response to monoamine |
| response to catecholamine |
| cardiac septum development |
| regulation of extent of cell growth |
| positive regulation of transporter activity |
| response to alkaloid |
| regulation of transforming growth factor beta receptor signaling pathway |
| negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| regulation of cellular response to transforming growth factor beta stimulus |
| synaptic vesicle cycle |
| transition metal ion transport |
| positive regulation of cell-substrate adhesion |
| cardiac ventricle development |
| growth cone |
| vesicle-mediated transport in synapse |
| cellular response to ammonium ion |
| G2/M transition of mitotic cell cycle |
| cellular response to reactive oxygen species |
| SH3 domain binding |
| cell cycle G2/M phase transition |
| positive regulation of cation transmembrane transport |
| regulation of G protein-coupled receptor signaling pathway |
| negative regulation of cellular response to growth factor stimulus |
| dendritic spine |
| response to ionizing radiation |
| positive regulation of cell morphogenesis involved in differentiation |
| positive regulation of ion transmembrane transport |
| midbody |
| trans-Golgi network |
| cardiac chamber development |
| cellular response to radiation |
| establishment of vesicle localization |
| antigen processing and presentation of exogenous peptide antigen |
| lamellipodium |
| regulation of reactive oxygen species metabolic process |
| regulation of cell size |
| negative regulation of cell projection organization |
| antigen processing and presentation of exogenous antigen |
| regulation of axonogenesis |
| response to ammonium ion |
| vesicle localization |
| antigen processing and presentation of peptide antigen |
| response to reactive oxygen species |
| postsynaptic membrane |
| regulation of plasma membrane bounded cell projection assembly |
| positive regulation of transmembrane transport |
| regulation of cell projection assembly |
| regulation of endocytosis |
| regulation of cell-substrate adhesion |
| cellular response to toxic substance |
| antigen processing and presentation |
| regulation of organelle assembly |
| cellular response to inorganic substance |
| regulation of synapse structure or activity |
| regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| receptor-mediated endocytosis |
| microtubule binding |
| cellular response to oxidative stress |
| regulation of Ras protein signal transduction |
| postsynaptic density |
| cytoplasmic vesicle |
| protein-containing complex localization |
| regulation of ion transmembrane transporter activity |
| regulation of transmembrane transporter activity |
| protein-containing complex binding |
| synapse |
| endosome |
| mitotic cell cycle phase transition |
| regulation of cellular response to growth factor stimulus |
| positive regulation of ion transport |
| regulation of transporter activity |
| cell cycle phase transition |
| axon |
| vesicle organization |
| response to xenobiotic stimulus |
| regulation of cell morphogenesis involved in differentiation |
| response to light stimulus |
| cellular response to environmental stimulus |
| cellular response to abiotic stimulus |
| microtubule |
| regulation of developmental growth |
| phagocytosis |
| GTPase activity |
| regulation of cation transmembrane transport |
| regulation of small GTPase mediated signal transduction |
| enzyme binding |
| glutamatergic synapse |
| regulation of neurotransmitter levels |
| establishment of organelle localization |
| Golgi vesicle transport |
| negative regulation of organelle organization |
| regulation of cellular component size |
| positive regulation of cell projection organization |
| regulation of metal ion transport |
| response to oxidative stress |
| GTP binding |
| cellular response to drug |
| positive regulation of cell adhesion |
| focal adhesion |
| regulation of cell growth |
| establishment of protein localization to organelle |
| response to radiation |
| protein kinase binding |
| regulation of ion transmembrane transport |
| neuron projection morphogenesis |
| plasma membrane bounded cell projection morphogenesis |
| blood vessel development |
| regulation of cell morphogenesis |
| cell projection morphogenesis |
| centrosome |
| regulation of neuron projection development |
| response to toxic substance |
| vasculature development |
| cell part morphogenesis |
| regulation of anatomical structure size |
| cardiovascular system development |
| positive regulation of cellular component biogenesis |
| heart development |
| response to inorganic substance |
| positive regulation of cell development |
| cellular response to organic cyclic compound |
| spermatogenesis |
| regulation of vesicle-mediated transport |
| endocytosis |
| regulation of transmembrane transport |
| male gamete generation |
| organelle localization |
| protein-containing complex |
| mitotic cell cycle process |
| cellular response to organonitrogen compound |
| Golgi membrane |
| metal ion transport |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| regulation of neuron differentiation |
| cellular response to nitrogen compound |
| neuron projection development |
| regulation of growth |
| import into cell |
| regulation of cell adhesion |
| mitotic cell cycle |
| gamete generation |
| regulation of plasma membrane bounded cell projection organization |
| positive regulation of cell death |
| perinuclear region of cytoplasm |
| regulation of ion transport |
| negative regulation of cellular component organization |
| regulation of cell projection organization |
| cell morphogenesis |
| protein localization to organelle |
| neuron development |
| regulation of neurogenesis |
| cellular component morphogenesis |
| multicellular organismal reproductive process |
| cation transport |
| sexual reproduction |
| multicellular organism reproduction |
| membrane organization |
| circulatory system development |
| response to organic cyclic compound |
| regulation of nervous system development |
| regulation of cell development |
| regulation of cellular component biogenesis |
| positive regulation of cell differentiation |
| Golgi apparatus |
| positive regulation of transport |
| multi-organism reproductive process |
| cell cycle process |
| response to organonitrogen compound |
| neuron differentiation |
| response to drug |
| cellular response to oxygen-containing compound |
| regulation of anatomical structure morphogenesis |
| response to nitrogen compound |
| plasma membrane bounded cell projection organization |
| response to abiotic stimulus |
| cell projection organization |
| positive regulation of cellular component organization |
| cellular response to endogenous stimulus |
| negative regulation of signal transduction |
| regulation of organelle organization |
| cell cycle |
| negative regulation of cell communication |
| negative regulation of signaling |
| positive regulation of developmental process |
| ion transport |
| reproductive process |
| reproduction |
| response to endogenous stimulus |
| protein transport |
| generation of neurons |
| peptide transport |
| regulation of apoptotic process |
| positive regulation of transcription, DNA-templated |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| amide transport |
| cellular protein localization |
| cellular macromolecule localization |
| establishment of protein localization |
| negative regulation of response to stimulus |
| neurogenesis |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| cell development |
| regulation of cell death |
| cellular response to stress |
| positive regulation of RNA metabolic process |
| positive regulation of molecular function |
| regulation of cell differentiation |
| regulation of intracellular signal transduction |
| establishment of localization in cell |
| nitrogen compound transport |
| regulation of transport |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| vesicle-mediated transport |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| membrane |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| PSMD1 | 0.512 |
| NARFL | 0.483 |
| PRPF19 | 0.477 |
| PAN3 | 0.476 |
| ISCU | 0.476 |
| TCEB3CL2 | 0.473 |
| ZFAND5 | 0.471 |
| CWC22 | 0.47 |
| TBC1D3E | 0.469 |
| TBC1D3C | 0.469 |
| TCEB3C | 0.469 |
| TBC1D3K | 0.469 |
| TBC1D3L | 0.469 |
| TBC1D3I | 0.469 |
| TBC1D3G | 0.467 |
| TBC1D3H | 0.467 |
| PSMD3 | 0.461 |
| PSMA6 | 0.458 |
| KCTD17 | 0.453 |
| DDTL | 0.452 |
| INTS6 | 0.449 |
| VASN | 0.448 |
| COPA | 0.448 |
| TGFBRAP1 | 0.448 |
| PSMD11 | 0.446 |
| BCL2L2 | 0.445 |
| ADAMTS16 | 0.443 |
| PSMD7 | 0.442 |
| SMG1 | 0.441 |
| FAM160A1 | 0.441 |
| MTCH2 | 0.438 |
| TBC1D3F | 0.438 |
| SUPT6H | 0.436 |
| KIF3C | 0.436 |
| TCEB3CL | 0.432 |
| ANKLE2 | 0.43 |
| CGB2 | 0.427 |
| CHAF1A | 0.425 |
| NUP160 | 0.425 |
| PSMC1 | 0.424 |
| TFRC | 0.424 |
| TICRR | 0.423 |
| RAD51 | 0.422 |
| ZNF106 | 0.422 |
| C14orf93 | 0.421 |
| RPS9 | 0.42 |
| TBC1D3 | 0.419 |
| PSMC3 | 0.419 |
| UPF1 | 0.419 |
| INTS5 | 0.417 |
| EXOSC3 | 0.416 |
| PSMA7 | 0.415 |
| RPL35 | 0.413 |
| CHD4 | 0.413 |
| CEBPZ | 0.412 |
| RBM39 | 0.412 |
| RPS28 | 0.411 |
| GPRIN2 | 0.411 |
| MT1E | 0.41 |
| SETD1A | 0.409 |
| POLE | 0.409 |
| SCAF1 | 0.409 |
| COPE | 0.409 |
| SF3B2 | 0.409 |
| RPSA | 0.408 |
| RAD21 | 0.408 |
| PLK1 | 0.408 |
| NOL12 | 0.407 |
| ACO2 | 0.406 |
| AKIRIN2 | 0.405 |
| SPRR2B | 0.404 |
| VPS54 | 0.402 |
| SRSF1 | 0.401 |
| OR10G3 | 0.401 |
| NBPF10 | 0.4 |
| SPRR2A | 0.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 22/28 |
| blood | 28/28 |
| bone | 18/26 |
| breast | 29/33 |
| central nervous system | 34/56 |
| cervix | 3/4 |
| colorectal | 11/17 |
| esophagus | 9/13 |
| fibroblast | 1/1 |
| gastric | 13/16 |
| kidney | 12/21 |
| liver | 17/20 |
| lung | 51/75 |
| lymphocyte | 15/16 |
| ovary | 21/26 |
| pancreas | 18/24 |
| peripheral nervous system | 3/16 |
| plasma cell | 15/15 |
| prostate | 1/1 |
| skin | 23/24 |
| soft tissue | 6/9 |
| thyroid | 0/2 |
| upper aerodigestive | 19/22 |
| urinary tract | 24/29 |
| uterus | 3/5 |
Expression Distribution